A registrational trial of RM-1929

Trial Profile

A registrational trial of RM-1929

Phase of Trial: Phase III

Latest Information Update: 16 Jan 2018

At a glance

  • Drugs RM 1929 (Primary)
  • Indications Head and neck cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Aspyrian Therapeutics
  • Most Recent Events

    • 16 Jan 2018 This trial is expected to begin in the first quarter of 2018, according to an Aspyrian Therapeutics media release.
    • 21 Jul 2017 New trial record
    • 19 Jul 2017 According to an Aspyrian Therapeutics media release, the company plans to initiate this trial in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top